Combined renin-angiotensin system gene polymorphisms and outcomes in coronary artery disease - a preliminary report.
Journal Title: Kardiologia Polska - Year 2011, Vol 69, Issue 7
Abstract
Background: Common variants of the renin-angiotensin system (RAS) genes have been linked to a higher risk of coronary artery disease (CAD) and its complications. Aim: To determine the prognostic significance of a combination of three common polymorphisms of RAS genes (angiotensin converting enzyme - ACE Ins/Del, angiotensin receptor type 1 - AGT1R A1166C and angiotensinogen - ATG M235T) in patients with CAD. Methods: The study included 216 patients (mean age 58 ± 9 years, 74% male) prospectively followed for a mean 41 ± 17 months. The end-points were all-cause mortality, myocardial infarction, stroke or the need for coronary revascularisation. Results: An end-point occurred in 41 (19%) patients. None of the polymorphisms analysed separately was associated with the end-point. Odds ratios were calculated for different combinations of analysed alleles to determine their relation to outcomes. Based on the cut-off points of odds ratios, the study group was divided into three subgroups: 55 patients without ATG 235T allele (T- subgroup); 100 patients with ATG 235T allele alone or ATG 235T allele combined with ACE Del allele or AGT1R 1166C allele (T+ or T+1 subgroup); and 61 patients with all three variants (T+2 subgroup). Multivariate analysis showed that the only independent predictor of the endpoint was an increasing number of variant genes (HR = 2.6, 95% CI 1.4-4.9, p = 0.002). Conclusions: Co-existing angiotensinogen M235T AGT polymorphism and two other common polymorphisms of the RAS genes are related to adverse events in patients with CAD. Kardiol Pol 2011; 69, 7: 688-695.
Authors and Affiliations
Zofia Dzielińska, Lukasz A Małek, Marta Roszczynko, Małgorzata Szperl, Marcin Demkow, Jacek Kądziela, Aleksander Prejbisz, Tomasz Zieliński, Andrzej Januszewicz, Witold Rużyłło
Keywords
Related Articles
- EP ID EP85728
- DOI -
- Views 106
- Downloads 0
[Stem cells in cardiological clinical trials].
Stem cell-based therapy is a novel therapeutic strategy introduced into cardiology, although there are not any established standards within the stem/progenitor cell type employed, their preparation, rout of administratio...
[Cardio-renal syndrome in patients with heart failure: pathophysiology, epidemiology and clinical significance.]
Radial vs femoral approach with StarClose clip placement for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. RADIAMI II: a prospective, randomised, single centre trial.
Background: Compared to the transfemoral approach (TFA), the transradial approach (TRA) for primary percutaneous coronary intervention (PCI) is associated with less risk of access site complications, greater patient comf...
Predictors of infarct-related artery patency following combined lytic therapy in patients with ST-segment elevation myocardial infarction treated with immediate percutaneous coronary intervention.
Patency of infarct-related artery (IRA) before percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) is associated with better outcomes. Little is known of the clinical or angiographic p...
[Chronic ischaemic mitral regurgitation. Part I: epidemiology, pathogenesis and diagnosis].